1Other quality system
Deficiencies were noted with the procedure for the assessment of returned drugs being considered for resale.
Inspection Record
MediPharm Labs Inc. — Health Canada Inspection Findings
View the regulator's official source The source document is always the basis for judgement.
Findings
2Equipment and facility
Evaluation of production processes, equipment, and/or materials was inadequate.
3Complaint and recall handling
The written procedures for recalls were inadequate.
4Other quality system
The purified water system was inadequate with the potential for water not meeting the appropriate requirements for chemical and microbial purity.
About this record
Extracted automatically from the document of the Health Canada inspection on 2021-05-12. The source is available at the link above.
This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.
Translation and classification are automated and may differ in nuance from the source.
